Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men

Cancer Epidemiology

Volumn 34, Issue 3, 2010, Pages 345-349

  Karatzas, Anastasios ^a   Giannatou, Eirini ^a   Tzortzis, Vassilios ^a   Gravas, Stavros ^a   Aravantinos, Evangellos ^a   Moutzouris, George ^a   Melekos, Michael ^a   Tsezou, Aspasia ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Estrogen glucuronidation; Prostate cancer; UGT1A1 gene polymorphisms

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A1;

AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COMPUTER PROGRAM; CONTROLLED STUDY; DNA SEQUENCE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLEASON SCORE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; MEN'S HEALTH; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER;

AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 77952237286     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.02.009     Document Type: Article

References (42)

1. Bosland M.C. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 27 (2000) 39-66
2. Yager J.D., and Liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 36 (1996) 203-232
3. King C.D., Rios G.R., Green M.D., and Tephly T.R. UDP-glucuronosyltransferases. Curr Drug Metab 1 September (2) (2000) 143-161
4. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Belanger A., et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7 August (4) (1997) 255-269
5. Senafi S.B., Clarke D.J., and Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303 Pt 1 (1994 Oct 1) 233-240
6. Vallee M., Albert C., Beaudry G., Hum D.W., and Belanger A. Isolation and characterization of the monkey UDP-glucuronosyltransferase cDNA clone monUGT1A01 active on bilirubin and estrogens. J Steroid Biochem Mol Biol 77 June (4-5) (2001) 239-249
7. Albert C., Barbier O., Vallee M., Beaudry G., Belanger A., and Hum D.W. Distribution of uridine diphosphate-glucuronosyltransferase (UGT) expression and activity in cynomolgus monkey tissues: evidence for differential expression of steroid-conjugating UGT enzymes in steroid target tissues. Endocrinology 141 July (7) (2000) 2472-2480
8. Cheng Z., Rios G.R., King C.D., Coffman B.L., Green M.D., Mojarrabi B., et al. Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7. Toxicol Sci 45 September (1) (1998) 52-57
9. Beutler E., Gelbart T., and Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad Sci USA 95 July (14) (1998) 8170-8174
10. Bosma P.J., Chowdhury J.R., Bakker C., Gantla S., de Boer A., Oostra B.A., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333 November (18) (1995) 1171-1175
11. Dutton G.J. Developmental aspects of drug conjugation, with special reference to glucuronidation. Annu Rev Pharmacol Toxicol 18 (1978) 17-35
12. Brossner C., Bayer G., Madersbacher S., Kuber W., Klingler C., and Pycha A. Twelve prostate biopsies detect significant cancer volumes (>0.5 mL). BJU Int 85 April (6) (2000) 705-707
13. Kavazarakis E., Tsezou A., Tzetis M., Hadjidimoula A., Kitsiou S., Kanavakis E., et al. Gilbert syndrome: analysis of the promoter region of the uridine diphosphate-glucuronosyltransferase 1 gene in the Greek population. Eur J Pediatr 159 November (11) (2000) 873-874
14. Gudmundsson J., Sulem P., Gudbjartsson D.F., Blondal T., Gylfason A., Agnarsson B.A., et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 41 October (10) (2009) 1122-1126
15. Gudmundsson J., Sulem P., Rafnar T., Bergthorsson J.T., Manolescu A., Gudbjartsson D., et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 40 March (3) (2008) 281-283
16. Al Olama A.A., Kote-Jarai Z., Giles G.G., Guy M., Morrison J., Severi G., et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 41 October (10) (2009) 1058-1060
17. Chouinard S., Pelletier G., Belanger A., and Barbier O. Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium. Endocr Res 30 November (4) (2004) 717-725
18. Barbier O., Lapointe H., El Alfy M., Hum D.W., and Belanger A. Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry. J Clin Endocrinol Metab 85 December (12) (2000) 4819-4826
19. MacLeod S.L., Nowell S., Plaxco J., and Lang N.P. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol 7 December (10) (2000) 777-782
20. Hajdinjak T., and Zagradisnik B. Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: frequency of DD homozygotes increases with Gleason Score. Prostate 59 June (4) (2004) 436-439
21. Park J., Chen L., Shade K., Lazarus P., Seigne J., Patterson S., et al. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer. J Urol 171 June (6 Pt 1) (2004) 2484-2488
22. Okugi H., Nakazato H., Matsui H., Ohtake N., Nakata S., and Suzuki K. Association of the polymorphisms of genes involved in androgen metabolism and signaling pathways with familial prostate cancer risk in a Japanese population. Cancer Detect Prev 30 3 (2006) 262-268
23. Park J., Chen L., Ratnashinge L., Sellers T.A., Tanner J.P., Lee J.H., et al. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol Biomarkers Prev 15 August (8) (2006) 1473-1478
24. Park J.Y., Tanner J.P., Sellers T.A., Huang Y., Stevens C.K., Dossett N., et al. Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. Urology 70 August (2) (2007) 374-379
25. Karypidis A.H., Olsson M., Andersson S.O., Rane A., and Ekstrom L. Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. Pharmacogenomics J 8 April (2) (2008) 147-151
26. Olsson M., Lindstrom S., Haggkvist B., Adami H.O., Balter K., Stattin P., et al. The UGT2B17 gene deletion is not associated with prostate cancer risk. Prostate 68 April 5 (2008) 571-575
27. Gsur A., Preyer M., Haidinger G., Schatzl G., Madersbacher S., Marberger M., et al. A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11 May (5) (2002) 497-498
28. Gallagher C.J., Kadlubar F.F., Muscat J.E., Ambrosone C.B., Lang N.P., and Lazarus P. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detect Prev 31 4 (2007) 310-315
29. Guillemette C., Millikan R.C., Newman B., and Housman D.E. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 60 February (4) (2000) 950-956
30. Guillemette C., De Vivo I., Hankinson S.E., Haiman C.A., Spiegelman D., Housman D.E., et al. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev 10 June (6) (2001) 711-714
31. Tsezou A., Tzetis M., Giannatou E., Gennatas C., Pampanos A., Kanavakis E., et al. Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women. Genet Test 11 Fall (3) (2007) 303-306
32. Duguay Y., McGrath M., Lepine J., Gagne J.F., Hankinson S.E., Colditz G.A., et al. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk. Cancer Res 64 February (3) (2004) 1202-1207
33. Cecchin E., Russo A., Corona G., Campagnutta E., Martella L., Boiocchi M., et al. UGT1A1*28 polymorphism in ovarian cancer patients. Oncol Rep 12 August (2) (2004) 457-462
34. van der Logt E.M., Bergevoet S.M., Roelofs H.M., van Hooijdonk Z., te Morsche R.H., Wobbes T., et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 25 December (12) (2004) 2407-2415
35. Kohle C., Mohrle B., Munzel P.A., Schwab M., Wernet D., Badary O.A., et al. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol 65 May (9) (2003) 1521-1527
36. Tukey R.H., Strassburg C.P., and Mackenzie P.I. Pharmacogenomics of human UDP-glucuronosyltransferases and irinotecan toxicity. Mol Pharmacol 62 September (3) (2002) 446-450
37. Fodstad P., Bjoro T., Torlakovic G., and Fossa S.D. No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer. J Urol 168 September (3) (2002) 1188-1192
38. Zintzaras E., and Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet 53 1 (2008) 1-9
39. Zintzaras E., and Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61 July (7) (2008) 634-645
40. Kitsios G.D., and Zintzaras E. Genomic convergence of genome-wide investigations for complex traits. Ann Hum Genet 73 September (Pt 5) (2009) 514-519
41. Kitsios G.D., and Zintzaras E. Genome-wide association studies: hypothesis-"free" or "engaged"?. Transl Res 154 October (4) (2009) 161-164
42. Thompson I.M., Pauler D.K., Goodman P.J., Tangen C.M., Lucia M.S., Parnes H.L., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 350 May (22) (2004) 2239-2246